COPD

A pulmonologist answers some of the most common questions he hears from colleagues and students about COPD exacerbations and their management.

COPD… nasal polyps.. gout …. dyskinesia in Parkinson Disease: here’s a brief look at new drugs for these and other disorders coming your way.

HRT, tattoos, insurers exacerbating the opioid epidemic, prolonged sitting, plus a new COPD drug: here's a recap of 5 of the week's key news reports.

Among the 13 new genes identified in this genome-wide association study, 4 have never before been linked to lung function.

A new study reports the impact on work productivity and lifestyle of undertreated COPD in the US, Europe, and China.

Take this quick quiz to test your knowledge of the disease and the latest guidance for improving patient care.

There are no optimal markers to predict mortality in COPD but results of a new study support further investigation of CRP.

Important revisions to the GOLD recommendations include a new definition of COPD and refined diagnostic categories.

A recent literature review found that up to 90% of COPD patients experience ADL-limiting morning symptoms.

Results of a new study suggest that racial inequalities in COPD, especially in women, may be shaped by socioeconomic factors.

The Breathlessness, Cough and Sputum Scale, used to evaluate COPD treatment efficacy, may help predict exacerbations in severe disease.

The CASCADE study found the biomarker of inflammation CRP associated with higher COPD symptom burden.

A new study sought to clarify conflicting findings on the impact of supplemental oxygen on exacerbations, hospitalization, and quality of life.

A new 5-question COPD assessment tool may help identify more serious disease earlier in the primary care setting.

The combination of heat and in-home air pollutants is dangerous, but also modifiable, say authors of a new study.

But are acute respiratory events associated with a decline in lung function in smokers without airway obstruction?

Responsiveness is consistent over the short term in individual patients but highly variable between patients.

Findings reported at the European Respiratory Society meeting point to "yes;" the effect size of decline in FEV1 may surprise you.

One-third of young adults (mid-20s) who had persistent asthma in childhood met GOLD criteria for obstructive lung disease.

Depression in COPD patients is one of the most common, yet least recognized comorbidities, with prevalence ranging from 17% to 44%.

Identifying risk, a promising mortality biomarker, and a new app for study recruitment-just a few of the latest developments in COPD research and patient care.

Vitamins C and E, in particular, have a beneficial effect on COPD risk and lung function in men, a new study found.

Effective asthma care requires attention to comorbidities, complications, and human characteristics of each patient. Speakers at CHEST 2015 described "the village."

New approaches discussed at CHEST 2015 ranged from the impact of bariatric surgery on asthma control to endobronchial valve placement in COPD.

In a well-attended session at CHEST 2015 a number of promising new therapies for treating COPD were reviewed by study authors.